{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T19:55:11Z","timestamp":1696362911078},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.clinthera.2007.08.002","type":"journal-article","created":{"date-parts":[[2007,10,4]],"date-time":"2007-10-04T14:45:34Z","timestamp":1191509134000},"page":"1632-1644","source":"Crossref","is-referenced-by-count":2,"title":["Oral Garenoxacin in the Treatment of Acute Bacterial Maxillary Sinusitis: A Phase II, Multicenter, Noncomparative, Open-Label Study in Adult Patients Undergoing Sinus Aspiration"],"prefix":"10.1016","volume":"29","author":[{"given":"J.","family":"Lopez Sisniega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Profant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rom","family":"Kostrica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hetty","family":"Waskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.08.002_bib1","first-page":"2","article-title":"Medical management of acute bacterial sinusitis. Recommendations of a clinical advisory committee on pediatric and adult sinusitis","volume":"182","author":"Brook","year":"2000","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"10.1016\/j.clinthera.2007.08.002_bib2","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1016\/S0002-9343(98)00352-0","article-title":"A focus on acute sinusitis in adults: Changes in disease management","volume":"106","author":"Poole","year":"1999","journal-title":"AmJ Med"},{"key":"10.1016\/j.clinthera.2007.08.002_bib3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1056\/NEJMcp035553","article-title":"Clinical practice. Acute bacterial sinusitis","volume":"351","author":"Piccirillo","year":"2004","journal-title":"N EnglJ Med"},{"issue":"Suppl 6","key":"10.1016\/j.clinthera.2007.08.002_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2004.09.029","article-title":"Rhinosinusitis: Establishing definitions for clinical research and patient care","volume":"114","author":"Meltzer","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clinthera.2007.08.002_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1067\/mhn.2000.107873","article-title":"Antimicrobial treatment guidelines for acute bacterial rhinosinusitis","volume":"123","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clinthera.2007.08.002_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998-2000: Susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0732-8893(03)00002-6","article-title":"Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8331 isolates from communiw-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999\u20132001)","volume":"45","author":"Jones","year":"2003","journal-title":"Diagn Microbiol Infect Dis."},{"key":"10.1016\/j.clinthera.2007.08.002_bib8","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/AAC.40.12.2884","article-title":"Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: Results of a 30-center national surveillance study","volume":"40","author":"Doern","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0732-8893(97)00195-8","article-title":"Surveillance of antimicrobial resistance in Streptococcus pneurnoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996\u20131997 respiratory season","volume":"29","author":"Thornsberry","year":"1997","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.002_bib10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2007.08.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.1135","article-title":"Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections","volume":"15","author":"Furuno","year":"2006","journal-title":"Pharmacoepidemiol Drug Sag"},{"key":"10.1016\/j.clinthera.2007.08.002_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM200207043470115","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"347","author":"Ross","year":"2002","journal-title":"N Engl J Med."},{"key":"10.1016\/j.clinthera.2007.08.002_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.08.002_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.10229","article-title":"Levofloxacin failure in a patient with pneumococcal pneumonia","volume":"35","author":"Empey","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0149-2918(02)85023-8","article-title":"A multicenter, randomized, investigator-blinded study of 5\u2212 and 10-day gatifloxacin versus 10-day amoxicillin\/clavulanate in patients with acute bacterial sinusitis","volume":"24","author":"Sher","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.08.002_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/rmed.1999.0769","article-title":"A comparison of the safety and efficacy of moxifloxacin (BAY 12\u20138039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults","volume":"94","author":"Siegert","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.clinthera.2007.08.002_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/147323000303100513","article-title":"Moxifloxacin in the treatment of acute maxillary sinusitis after first-line treatment failure and acute sinusitis with high risk of complications","volume":"31","author":"Gehanno","year":"2003","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2007.08.002_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0732-8893(00)00233-9","article-title":"Activiy and spectrum of BMS 284756, a new des-F(6) quinolone, tested against strains ofciprofloxacin-resistant gram-positive cocci","volume":"39","author":"Jones","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.002_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1128\/AAC.43.5.1077","article-title":"In vitro and in vivo antimicrobial activities ofT-3811 ME, a novel des-F(6)-qu inolone","volume":"43","author":"Takahata","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1128\/AAC.46.1.234-238.2002","article-title":"Antimicrobial activities of BMS-284756 compared with those of fluoro-quinolones and beta-lactams against gram-positive clinical isolates","volume":"46","author":"Bassetti","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jac\/48.3.446","article-title":"Comparison of the in vitro activities of BMS-284756 and four fluoroquinolones against Streptococcus pneumoniae","volume":"48","author":"Boswell","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib22","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1128\/AAC.48.3.765-773.2004","article-title":"Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model","volume":"48","author":"Azoulay-Dupuis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jac\/dkl159","article-title":"Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae","volume":"58","author":"Zhanel","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/AAC.46.1.191-195.2002","article-title":"Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations","volume":"46","author":"Lawrence","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0732-8893(01)00224-3","article-title":"Activity of BMS284756 against 2681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States","volume":"39","author":"Biedenbach","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.002_bib26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.45.5.1463-1466.2001","article-title":"Activities of BMS 284756 (%3811 ) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999)","volume":"45","author":"Gales","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib27","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dki348","article-title":"Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients","volume":"56","author":"Edmiston","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib28","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1128\/AAC.47.7.2256-2263.2003","article-title":"Multiple-dose safety and pharmacokinetics of oral garenoxacin in healthy subjects","volume":"47","author":"Gajjar","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib29","series-title":"Presented at: 37th Annual American Society of Health-System Pharmacists Midyear Clinical Meeting","article-title":"Absolute oral bioavailability of garenoxacin tablets and the bioequivalence of the intravenous formulation with respect to oral tablets","author":"Bello","year":"2002"},{"key":"10.1016\/j.clinthera.2007.08.002_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jac\/dkg110","article-title":"Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects","volume":"51","author":"Andrews","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2007.08.002_bib31","series-title":"Presented at: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Safety, tolerability and pharmacokinetics of BMS-284756, a novel des-F(6)-quinolone, following 28 days of once daily oral dosing in healthy subjects","author":"Stewart","year":"2001"},{"key":"10.1016\/j.clinthera.2007.08.002_bib32","series-title":"Presented at: 39th Annual Meeting of the Infectious Disease Society of America","article-title":"AUC\/MIC ratio and duration of therapy both influence the probability of emergence of resistance to a fluoroquinolone in an in vitro hollow fiber infection model (IVHFIM)","author":"Tam","year":"2001"},{"key":"10.1016\/j.clinthera.2007.08.002_bib34","series-title":"ICH Topic E6","article-title":"Guide-line for Good Clinical Practice [EMEA Web site]","year":"2002"},{"key":"10.1016\/j.clinthera.2007.08.002_bib35","series-title":"Approved standard M7-AS","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2000"},{"key":"10.1016\/j.clinthera.2007.08.002_bib36","series-title":"Coding System for Thesaurus of Adverse Reaction Terms (COSTART)","year":"1995"},{"key":"10.1016\/j.clinthera.2007.08.002_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/000348949910800704","article-title":"Resistance to antimicrobials used for therapy of otitis media and sinusitis: Effect of previous antimicrobial therapy and smoking","volume":"108","author":"Brook","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.clinthera.2007.08.002_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1177\/000348949910800408","article-title":"Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis","volume":"108","author":"Clifford","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.clinthera.2007.08.002_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1081-1206(10)62742-1","article-title":"Sparfloxacin for the treatment of acute bacterial maxillary sinusitis documented by sinus puncture","volume":"84","author":"Garrison","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2007.08.002_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/030006059802600602","article-title":"Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: A multicentre, double-blind, randomized study","volume":"26","author":"Lasko","year":"1998","journal-title":"J Int Med Res"},{"key":"10.1016\/j.clinthera.2007.08.002_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.otohns.2005.11.026","article-title":"A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis","volume":"134","author":"Poole","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clinthera.2007.08.002_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6815-6-8","article-title":"Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis","volume":"6","author":"Ariza","year":"2006","journal-title":"BMC Ear Nose Throat Disord"},{"key":"10.1016\/j.clinthera.2007.08.002_bib43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/S1413-86702005000200007","article-title":"An open multicenter study of-the use of gatifloxacin for the treatment of-non-complicated acute bacterial rhinosinusitis in adults","volume":"9","author":"Weckx","year":"2005","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.clinthera.2007.08.002_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2165\/00151829-200403050-00001","article-title":"Short-course therapy for acute sinusitis: How long is enough?","volume":"3","author":"Elies","year":"2004","journal-title":"Treat Respir Med."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807002378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807002378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T14:43:10Z","timestamp":1556894590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807002378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0149291807002378"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.08.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}